Introduction
The aspartic proteinases (EC 3.4.23) are one of four main classes of endopeptidase and are generally characterized by a highly conserved bi-lobed structure, the presence of two aspartate residues near the active center (Asp32 and Asp215 by pepsin numbering) and inhibition by pepstatin (Tang and Wong, 1987; Davies, 1990) . Proteolytic specificity can range from extremely broad as in the case of pepsin, whose primary function is digestion of food, to very narrow in the case of renin, whose only known role is to cleave the hormone precursor angiotensinogen into its active form. Recently, two members of the aspartic proteinase gene family have been described that are catalytically inactive because of key mutations in the amino acids close to the active site (Xie et ai, 1991) . One of them, ovine pregnancy-associated glycoprotein-1 (ovPAG-1), lacks one of the two catalytic aspartic acid residues (Asp215; pepsin numbering) that participate in catalysis and is substituted by glycine. The other, boPAG-1, has an alanine in place of a normally invariant glycine (Gly34) residue whose presence would cause displacement of the catalytic water molecule from its normal position between the two catalytic aspartic residues (Asp32 and Asp215). Despite these anomalies, bo-and ovPAG-1 bind pepstatin (Xie et ai, 1991) and show ~50% sequence identity to pepsin. Their colocalization with placental lactogen in the hormone-producing placental binucleate cells of the placenta (Warren et ai, 1990; Zoli et ai, 1992a; Roberts et ai, 1994) and their presence in serum of pregnant cows (Sasser et ai, 1986; Humblot et ai, 1988; Zoli et ai, 1992b) , ewes (Ruder et ai, 1988) and other ruminants (Houston el ai, 1986; Wood et ai, 1986; Haigh et ai, 1991) have suggested that they may play a role in fetalmaternal communication, possibly by a mechanism involving their substrate-binding clefts. Subsequently several additional members of this gene family in both cattle (Xie et ai, 1994 (Xie et ai, , 1996 and sheep (Nagel et ai, 1993) have been identified and shown to be expressed largely if not exclusively in placenta. Southern genomic blotting of bovine (Xie et ai, 1996) , ovine and porcine DNA (unpublished results) indicates that multiple genes for PAG-related molecules exist in the different species.
Sequence alignment with animal aspartic proteinases has shown that the PAG molecules are most similar to the pepsins. This resemblance extends throughout the full-length of the molecules and has allowed us to construct three-dimensional models for boPAG-1 and ovPAG-1 based on the crystal structures of pepsin and chymosin. The objectives were to explore interactions with peptides within the binding site cleft of boPAG-1 and ovPAG-1 that might provide clues to their specificity, and to compare the peptide binding subsites of boPAG-1 and ovPAG-1 with pepsin and other PAGs, including those recently cloned from pigs and horses. Earlier studies have clearly demonstrated the value of comparative modelling techniques in exploring substrate interactions of aspartic proteinases (Scarborough etai, 1993; Guruprasad et ai, 1994; Naik et ai, 1995; Scarborough and Dunn, 1994 LGICFSSFEGNEDiaOJSEEWILGDVPLRLYFTVFDRENDRIGLATAV
Materials and methods

Cloning and sequencing of cDNA
The cDNAs were isolated from placental libraries of cattle, sheep, pigs and horses by standard procedures which have been described elsewhere (Xie etal, 1991 (Xie etal, , 1994 (Xie etal, , 1996 Nagel et ai, 1993; Green et al, 1994; Szafranska et a/., 1995) . The data are all derived from full-length cDNA clones which were sequenced fully in both directions by the dideoxy procedure. Amino acid sequences were aligned by using the program MALIGN (Johnson et al., 1993) (Figure 1 ). A phylogenetic tree was constructed on the basis of evolutionary distances derived from pairwise sequence identities by using the method of Fitsch and Margoliash (1967) . Modelling Three-dimensional models of boPAG-1 and ovPAG-1 were constructed using the rule-based comparative modelling approach encoded in the COMPOSER suite of computer programs (Sutcliffe et al, 1987a,b) . The models were based on the three-dimensional structures of porcine pepsin (PDB code 5PEP at 2.3 A resolution) (Cooper et al, 1990 ) and bovine chymosin (PDB code 4CMS at 2.2 A) (Newman et al, 1991) with which boPAG-1 and ovPAG-1 have >40% sequence identity ( Figure 2 ) and the disulphide connectivities in PAG were assumed to be identical with those in pepsin and chymosin. The structurally conserved regions (SCRs) used by COMPOSER to model the framework and the structurally variable regions (SVRs) are shown in Table I . The models were then refined by using energy minimization techniques in the SYBYL software (Tripos). The PROCHECK suite of programs (Laskowski et al, 1993) was used to evaluate the stereochemical quality of the models. Nearly 84% of the residues in the boPAG-1 model and about 87% of residues in the ovPAG-1 model were in the 'most favoured' regions of the Ramachandran map.
Modelling peptides/inhibitor in the binding subsites
In order to understand how an inhibitor/peptide might bind in the binding subsites, two inhibitors, which have been analysed as crystal structure complexes with other mammalian aspartic proteinases, were modelled separately into the binding-site cleft of boPAG-1 and ovPAG-1. Thus, the three-dimensional structures of mouse renin complexed with a decapeptide inhibitor CH-66 (PDB Code: 1SMR at 2.0 A) (DeAlwis et al, 1994) and human cathepsin D complexed with the pepstatin inhibitor (PDB Code: 1LYB at 2.5 A) (Baldwin et al, 1993) were used as guides to model the respective inhibitors in boPAG-1 and ovPAG-1. CH-66 was chosen because it is the longest inhibitor defined by X-ray analysis (as a complex widi mouse renin) and was valuable in defining the sites Sg to S 4 '. Pepstatin was chosen in order to understand the basis of its apparent ability to bind to boPAG-1 (S.Xie and R.M.Roberts, Fig. 1 . Alignment of the pregnancy-associated glycoprotein (PAG) sequences with those of porcine pepsin (SWISSPROT code: PORC_PEPSN) and bovine chymosin (CHYM_BOVIN) using the program MALIGN (Johnson et al., 1993) . Abbreviations' bo, bovine; ov, ovine; po, porcine; eq, equine. BoPAG-lv is the variant of boPAG-1. The numbering above PORC_PEPSN corresponds to the numbering in porcine pepsin as in the PDB code 5PEP and is corrected after residue number 230. Residues in PAG, which arc close to the binding subsites and different from porcine pepsin, are highlighted and shaded. Identical residues in all the sequences are marked with an asterisk. The potential glycosylation sites are underlined. The half cystines are shown in bold italics. unpublished results) and therefore to support future experimental studies on ligand binding. The inhibitor modelling was achieved by superimposing the model of boPAG-1 and ovPAG-1 on the crystal structures of the enzyme-inhibitor complexes and transferring the coordinates of the inhibitors onto the models. Small adjustments that were required to optimize the fit were carried out by FRODO (Jones and Thirup, 1986 ) and further refinement was achieved by using the energy minimization procedure in SYBYL. Interactions within the binding subsites between the PAG and inhibitor/peptide atoms were identified by a 4.0 A cut-off value. The residues in PAG that satisfy this criterion are listed in Tables II and ITI . The coordinates of the PAG models are deposited in the Brookhaven Protein Data Bank (codes for the models provided by the authors: BPAG1.PDB, bovine PAG-1 and OPAG1.PDB, ovine PAG-1).
Results and discussion
Sequence comparisons
An alignment of the amino acid sequences of porcine pepsin, bovine chymosin and all of the PAG molecules currently available is shown in Figure 1 . The numbering throughout corresponds to that of porcine pepsin (PDB code 5PEP). Partial sequences are available for several additional PAG from cattle and sheep, most likely reflecting the large numbers of genes that have been detected by Southern genomic blotting (Xie et ai, 1996) . The numbering system of PAG reflects the order in which PAG cDNA were cloned from each of the species. Fortuitously, there is limited immunological cross-reactivity between boPAG-1, ovPAG-1 and poPAG-1, while none exists between PAG-1 and PAG-2 molecules even within a species (Xie et ai, 1991; Szafranska et ai, 1995) . The boPAG-lv (v = variant) cDNA was identified by library screening with an anti-boPAG-1 antiserum and was sufficiently similar to boPAG-1 (91.5% identity at the nucleotide level) (Xie et ai, 1996) that it was not given a separate number. The sequences of all the PAG, except boPAG-1 and ovPAG-1, have been inferred entirely from their cloned cDNA. Limited sequencing of the N-termini of chromatographically purified boPAG-1 (Xie et ai, 1991) and ovPAG-1 (S.Xie and R.M.Roberts, unpublished results) has shown that the mature protein sequence of both begins at Arg4. As remarked upon previously, boPAG-1 and ovPAG-1 are almost certainly without enzymatic activity (Xie et ai, 1991) . The former because of a Gly-»Ala Thr74-Ser77
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Residues in the binding subsites that differ in the boPAG-1 and ovPAG-1 models are highlighted in bold.° A distance cut-off (4.0 A) was used to define the binding pockets; residues are numbered according to porcine pepsin (Protein Data Bank; Code 5PEP) (Bernstein el al.. 1977; Abola el al., 1987) . b CH-66-trimethylacetyl-His-Pro-Phe-His-Leu-v(CH(OH)CH 2 )-Leu-TyT-TyrSer-NH 2 c Pepstatin: Iva-Val-Val-Sta-Ala-Sta. substitution at position 34, the latter because one of the catalytic aspartic acid residues (Asp2l5) is replaced by Gly. Similar reasoning suggests poPAG-L, with an Ala instead of a Gly at position 34, is also likely to be inactive. The remaining PAG possess Consensus sequences around Asp32 and Asp215 found in active aspartic proteinases, so that catalytic activity cannot be ruled out on this basis. Figure 2 reflects the considerable degree of sequence identity existing between pepsin, chymosin and the PAGs. Sequence differences are not highly concentrated but are distributed throughout the full lengths of the molecules (Figure 1) . The similarity of boPAG-1 and ovPAG-1 to pepsin suggests that all three molecules are closely related and would possess a similar three-dimensional fold. In order to analyse their relatedness more rigorously, a phylogenic tree was constructed on the basis of amino acid sequence differences between the PAG, bovine chymosin and porcine pepsin (Figure 3 ). This analysis again emphasizes the relatedness of the PAG-1 of cattle and sheep and the distinctiveness of the PAG-1 and PAG-2 groupings. However, the porcine PAG-1 and -2 are more related to each other than they are to the comparably numbered PAG of cattle and sheep. This observation is consistent with the relatively early divergence within the Artiodactyls of the Suina and Ruminantia suborders between 55 and 60 million years ago ( Van Soest, 1982) . The even earlier split of the horses (order Perissodactyla) from the Artiodactyla order appears to be reflected in the fact that equine PAG most clearly resembles porcine pepsin and is the least related to the ruminant PAG.
The three-dimensional models
A schematic representation of the three-dimensional model of boPAG-1 ( Figure 4A) shows the overall arrangement of helices and strands and pepstatin in the binding subsites. The overall three-dimensional fold of ovPAG-1 (not shown) is very similar to that of boPAG-1. In ovPAG-1 ( figure not shown) , an extra half-cystine (Cys241) is exposed to the solvent and may be involved in dimerization through the formation of an intermolecular disulphide bridge.
Comparison of the models of ovPAG-1 (324 amino acids) with boPAG-1 (327 amino acids) shows that for 314 topologically equivalent C a -atoms in the two models, the root mean square deviation (r.m.s.d.) is 0.46 A (the five residues between Cys45 and Cys50 in ovPAG-1 which are distant from the binding site cleft were not modelled as an equivalent fragment to model this loop was not available from either within or outside the homologous family).
Comparison of the models with porcine pepsin and bovine chymosin showed that in each case the models were closer to porcine pepsin; boPAG-1 and porcine pepsin have an r.m.s.d. 
Binding subsites
The binding subsites for the two inhibitors (pepstatin and CH-66) complexed with boPAG-1 and ovPAG-1 are listed in Tables  II and III , respectively. We have compared the binding sites of porcine pepsin and PAG in order to identify possible differences in specificity (Figure 1 and Tables II and III) . The most obvious difference is in the charge distribution, which is shown for boPAG-1 in Figure 4 (B) calculated by GRASP (Nichols and Honig, 1991) . The electronegative charge at the binding sites is mainly due to the presence of Asp220 (S 4 subsite) and Asp 189 (S,' subsite) in addition to the catalytic Asp32 and Asp215 of boPAG-1. It suggests a preference for basic peptides in boPAG-1 and ov-PAG-1, whereas, in boPAG-2 and ovPAG-2 the equivalent residues are polar but not negatively charged.
There are also differences of hydrophobicity. For example, at the S 6 pocket the hydrophobic groups (leucine, isoleucine and methionine) in ovPAG-1, ovPAG-2, poPAG-1, poPAG-2 and eqPAG-1 imply preference for a hydrophobic residue at residue Pg, whereas boPAG-2, like pepsin, has a threonine (see Figure 1) . At the S4 pocket the specificity may be determined by the nature of residue 220 which is leucine in pepsin and cathepsin D. This residue together with Leu 12 interacts with the side chain of Iva of pepstatin. The presence of hydrophobic groups in boPAG-2 (Met220), poPAG-1 (Phe220) and poPAG-2 (Met220) should favour pepstatin binding, but the presence of Asp220 in boPAG-1 is likely to lead to weaker binding. S3 is a deep pocket that varies in hydrophobicity in different aspartic proteinases. PAGs may have an increased preference for hydrophobic residues, as residues such as 12, 13 and 117 tend to be hydrophobic. In contrast, mammalian aspartic proteinases have either glutamic acid or glutamine at position 13.
Large hydrophobic Sj and S/ pockets are characteristic of most aspartic proteinases and these are largely retained in PAGs. An exception is the tyrosine at position 189, which is conserved in all mammalian aspartic proteinases except mouse renin (Serl89) and human renin (Vail89). Non-aromatic residues are found in PAGs, for example Asp 189 (in boPAG-1 and boPAG-lv), Glul89 (in ovPAG-1), Serl89 (ovPAG-2) or His 189 (boPAG-2). These are likely to influence peptide binding specificities. In particular, the aspartic acid and glutamic acid substitutions at position 189 would probably reduce binding and, therefore, proteolytic activity except at low pH.
Phel30, which is conserved between boPAG-1, boPAG-lv and ovPAG-1, may also be important for specificity. In other PAGs it is replaced by isoleucine or valine. In the CH-66 model of boPAG-1, the side chain of Phel30 clashes with the residue at P 2 ' (Tyr) and P 3 ' (Tyr), possibly precluding tight peptide binding. In contrast, pepstatin binding would be less affected owing to the much smaller residue at P 2 ' (alanine).
Only one binding site may be affected by deletions in the main chain in PAGs. For example, residues 115 and 117 line the S, subsite. Deletions of one to three residues close to this region occur in the bovine and ovine PAGs.
The hydrogen bond interactions proposed between PAG and the two inhibitors are shown in Table IV . In general, it should be possible to form the same main chain to main chain bonds between PAGs and ligands as found in normal aspartic proteinases. In ovPAG-1 the hydrogen bond with side chain of Asp215 is not possible owing to the mutation (Asp215-Gly). In addition, in the case of poPAG-1 the hydrogen bond between the carbonyl oxygen of P 4 residue and the side chain of Ser219 is not possible owing to substitution by alanine. In boPAG-1, the side chain of Asn289 is likely to interact with the peptide via a side chain hydrogen bond with the NE 2 atom of His (P 2 ). This may not be possible in ovPAG-1 owing to Pro285 (unique to ovPAG-1) that is likely to alter the conformation of the backbone, leading to differences in the side chain orientation of Asn289 in the bovine and ovine PAG-1 molecules.
These observations are in general consistent with binding data which show that pepstatin interacts with various PAGs. Stereo-views illustrating the extended binding nature of pepstatin in boPAG-1 and ovPAG-1 are shown in Figure 4 (C) and (D), respectively. ovPAG-1 can be successfully trapped on affinity columns, along with other PAGs secreted simultaneously, from cultured ovine placental explants (R.J.Nagel and R.M.Roberts, unpublished results). The boPAG-2 and poPAG-2, after being expressed in the methanolic yeast Pischia pastoris, can be purified in a single-step procedure by affinity chromatography on a pepstatin-agarose column. The binding buffer is 50 mM sodium acetate buffer, pH 5.0, containing 200 mM NaCl, 2 mM EDTA, 0.2 mM phenylmethylsulphonyl fluoride (PMSF), 0.02% NaN 3 . The column is washed with 10 volumes of I M NaCl. The boPAG-2 is eluted with 20 mM Tris-HCl, pH 8.0, containing 1 M NaCl plus EDTA, PMSF and NaN 3 . poPAG-2 elution requires more stringent conditions involving pH 9.0 buffer (J.Green, S.Xie and R.M. Roberts, unpublished results) . The proteolytic activity of eqPAG-1 (prepared in a refolded recombinant product in Escherichia coli) towards its propeptide, is elirninated by a threefold molar excess of pepstatin (J.Green and R.M.Roberts, unpublished results).
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Positions and effects of glycosylation Asparagine residues that can potentially be A/-glycosylated on the different PAGs, i.e. present in the context Asn-X-Thr/Ser, are shown in Figure 1 . The anomalously high molecular weight of the PAG (-70 000) (Xie et ai, 1991 (Xie et ai, , 1994 may be due at least in part to glycosylation. Carbohydrate on certain ovPAG molecules has also been reported to contribute to their antigenicity (Atkinson et ai, 1993) . The models indicate that the side chains of Asn-1, Asn68 and Asnl27 of boPAG-1 are exposed to solvent, while that of Asnl7 may be partially buried ( Figure 4A ) owing to the close proximity of the side chains of Arg7, Glu26 and Gln28 (not shown in the figure) . Edman sequencing of ovPAG-1 has provided no signal on cycles 4 and 21 (positions -1 and 17, pepsin numbering) (S.Xie and R.M.Roberts, unpublished results). Therefore, both asparagines are likely to be glycosylated. In general these glycosylation sites are unlikely to inhibit substrate binding; the exception might be the N-linked carbohydrate chain in boPAG-2 and in eqPAG-1 at Asn294 which might interfere with peptide binding near the prime site subsites.
Are any of the PAG proteolytically active?
There are several residues that may affect catalytic activity. The substitution of Asp215 with glycine in ovPAG-1 provided the original basis for predicting that it would be proteolytically inactive, while the projection of the methyl group of Ala34 in boPAG-1 into the S, pocket would displace a water molecule that is required for catalysis (Xie et ai, 1991) . The C^-atom of Ala34 in boPAG-1 is within 2.0 A of the OH atom of P, in the CH-66 inhibitor model. A similar argument holds for the likely inactivity of poPAG-1, which also has alanine at position 34 (Figure 1) . Interactions with the 'flap' at position 75 are also important for activity as the ring hydrogens come close to the tetrahedral intermediate. Substitutions at position 75 in ovPAG-1 (Phe75) and in poPAG-1 (Pro75) (Figure 1 ) may reduce activity and also influence peptide binding in these two PAG, as will the replacement of the conserved Gly76 with histidine in poPAG-1.
Only poPAG-2 and eqPAG-1 have the complete consensus set of amino acids around the catalytic aspartic acid residues. Neither possesses unfavourable substitutions at residues 115, 117, 189, 289 and 300 and neither has deletions between Glu 107 and Asp 118. Both have relatively conservative substitutions for phenylalanine (isoleucine and valine, respectively) at position 130. The only major difference from pepsin is at position 12, where eqPAG-1 has isoleucine and poPAG-2 has a methionine. These observations are consistent with the observation that the unglycosylated recombinant eqPAG-1 synthesized in E.coli is active and can remove its own pro-peptide (J.Green and R.M. Roberts, unpublished results) . Experiments are in progress to determine whether poPAG-2 also has retained proteolytic activity. Conclusions Sequence analyses have strongly suggested that PAGs most closely resemble pepsin. This work supports the conclusion that their three-dimensional folds are also likely to be very similar to that of pepsin. Although neither the biological role nor substrate specificity of PAG molecules are yet known, we have suggested those residues that are most likely to influence the binding specificity in PAG molecules and have thus provided the basis for further biological and biochemical experiments. Of the known PAG, only poPAG-2 and eqPAG-1 are likely to have potential proteolytic activity and in the case of eqPAG-1 this has now been confirmed. If the functions of the PAGs are to bind small peptides in their clefts, then they will exhibit dissimilar specificities. Bovine and ovine PAG-1 may have a general affinity for binding peptides with basic residues. The PAG represent a family where the peptide binding function may have been retained but the catalytic activity, at least in boPAG-1, ovPAG-1 and poPAG-1, may have been lost owing to the critical mutations within the binding subsites.
